UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

In multiple sclerosis (MS), an alteration of neuronal metabolism caused by dysfunction of its proteasome, the cellular machinery responsible for recycling proteins, contributes to neurodegeneration in ...

People with multiple sclerosis (MS) often face higher unemployment rates. Understanding the available support can help you navigate employment and financial stability.

'World Multiple Sclerosis Day' is on May 3oth. The day is meant to highlight the disease that has no cure and its effects on the millions of people who live with the condition.

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also ...

From Christina Applegate to Selma Blair to Jack Osbourne, these celebrities have been candid about their journeys with multiple sclerosis Charley Gallay/Getty; Matt Winkelmeyer/Getty; JC Olivera ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Sidharthan, Chinta. (2024, November 06). Saturated fats accelerate neurodegeneration in multiple ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers ...

Kesimpta is a medicine used to treat relapsing forms of multiple sclerosis (MS).Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive ...